BrightView Health Arlington

BrightView Health Arlington

Services:
Education and Counseling Services
• Group counseling
• Individual counseling
• Substance use disorder education

Facility Vaping Policy

• Vaping permitted in designated area

Type of Opioid Treatment

• Accepts clients using MAT but prescribed elsewhere
• Prescribes naltrexone
• Relapse prevention with naltrexone
• Buprenorphine detoxification
• Maintenance service with medically supervised withdrawal after stabilization
• Prescribes buprenorphine
• Buprenorphine maintenance

License/Certification/Accreditation

• The Joint Commission

Detoxification (medical withdrawal) Services

• Opioids detoxification
• Methamphetamines detoxification
• Medication routinely used during detoxification
• Benzodiazepines Detoxification
• Cocaine Detoxification
• Alcohol Detoxification

Type of Care

• Detoxification
• Substance use treatment

Gender Accepted

• Male
• Female

Type of Alcohol Use Disorder Treatment

• This facility administers/prescribes medication for alcohol use disorder

Language Services

• Sign language services for the deaf and hard of hearing

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

• Outpatient day treatment or partial hospitalization
• Outpatient detoxification
• Regular outpatient treatment
• Outpatient
• Intensive outpatient treatment
• Outpatient methadone/buprenorphine or naltrexone treatment

Payment/Insurance/Funding Accepted

• Cash or self-payment
• Private health insurance
• Federal military insurance (e.g., TRICARE)
• State-financed health insurance plan other than Medicaid
• Medicare
• Medicaid

Recovery Support Services

• Assistance with obtaining social services
• Mentoring/peer support
• Housing services

Age Groups Accepted

• Adults
• Young Adults

Ancillary Services

• Case management service
• Social skills development

Assessment/Pre-treatment

• Screening for tobacco use
• Screening for substance use
• Comprehensive substance use assessment

External Source of Medications Used for Alcohol Use Disorder Treatment

• In-network prescribing entity

Facility Smoking Policy

• Smoking permitted in designated area

Treatment Approaches

• Matrix Model
• Motivational interviewing
• Telemedicine/telehealth therapy
• Trauma-related counseling
• Contingency management/motivational incentives
• Relapse prevention
• Brief intervention
• Substance use disorder counseling
• Community reinforcement plus vouchers
• Cognitive behavioral therapy

Testing

• Drug or alcohol urine screening

Special Programs/Groups Offered

• Adult women
• Pregnant/postpartum women
• Adult men

Opioid Medications used in Treatment

• Naltrexone used in Treatment
• Buprenorphine used in Treatment

External Opioid Medications Source

• In-network prescribing entity

Facility Operation (e.g., Private, Public)

• Private for-profit organization

Transitional Services

• Naloxone and overdose education
• Aftercare/continuing care
• Outcome follow-up after discharge
• Discharge Planning

Pharmacotherapies

• Naltrexone (oral)
• Disulfiram
• Buprenorphine (extended-release, injectable)
• Non-nicotine smoking/tobacco cessation
• Buprenorphine with naloxone
• Buprenorphine without naloxone
• Nicotine replacement
• Naltrexone (extended-release, injectable)
• Acamprosate (Campral®)
• Buprenorphine sub-dermal implant